In this video, Andres Deik, MD, MSEd, FAAN, discusses the results of the CYCLE-II trial, presented at the 2025 International Congress of Parkinson’s Disease and Movement Disorders.

A common chemical that is widespread in the U.S. has been linked to an increased risk of Parkinson’s disease, researchers say. In a recent study published in the journal Neurology, researchers found a ...

The first hint of a problem for Harry Zouros came in 2018. The fitness enthusiast who competed in high-endurance races noticed his hands began to shake and his left side didn't feel right. Still, he ...

Cell and gene therapies account for 20% of pipeline Parkinson's therapy bemdaneprocel in Phase 3 trial Pharma success urgently needed, says fund manager FRANKFURT, Sept 25 (Reuters) - Bayer's ...

Korean researchers have uncovered compelling evidence that oral bacteria, once colonized in the gut, can affect neurons in the brain and potentially trigger Parkinson's disease. The joint research ...

WILMINGTON, NC (WWAY-TV) — Parkinson’s disease impacts the lives of over 1.1 million people in the U.S., according to the Parkinson’s Foundation. While there is no known cure to the disease Novant ...

Trial results could underpin request for regulatory approval Bayer already working on manufacturing network Several other research teams working on similar treatments SAN SEBASTIAN, Spain, Sept 22 ...

Former special counsel Robert Mueller, who investigated ties between Russia and President Trump’s 2016 campaign, was diagnosed with Parkinson’s disease four years ago, his family told The New York ...

Robert Mueller, who served as a special counsel to determine if the Russian government interfered to help then-presidential candidate Donald Trump in 2016, was diagnosed with Parkinson’s disease four ...

ABSTRACT: A degenerative neurological condition called Parkinson disease (PD) that evolves progressively, making detection difficult. A neurologist requires a clear healthcare history from the ...